Evidence map›Paper›PMID 41585754›Full record

ArticleStroke (Hoboken, N.J.)2023

Endovascular Therapy of Tandem Occlusions: Baseline Characteristics and Outcomes Compared With Intracranial Occlusion.

Mads M Sørensen, Thabele M Leslie-Mazwi, Jonas Jensen, Jan B Valentin, Claus Z Simonsen

Abstract read
In one paragraph

Article in Stroke (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trial.International journal of stroke : official journal of the International Stroke Society · 2024
    Trial
  2. Management of tandem occlusions in acute ischaemic stroke.Therapeutic advances in neurological disorders · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mads M SørensenDepartment of Neurology Aarhus University Hospital Aarhus Denmark.
Thabele M Leslie-MazwiDepartment of Neurology University of Washington Seattle WA.
Jonas JensenNeuroradiology Aarhus University Hospital Aarhus Denmark.
Jan B ValentinDepartment of Clinical Medicine Aalborg University and Aalborg University Hospital Aalborg Denmark.
Claus Z SimonsenDepartment of Neurology Aarhus University Hospital Aarhus Denmark.ORCID https://orcid.org/0000-0003-1363-0266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Endovascular therapy is highly effective in stroke caused by large vessel occlusion. Guidelines support treatment in case of occlusion of the intracranial internal carotid artery or the first segment of the middle cerebral artery. We aimed to examine baseline characteristics and outcome of patients who underwent endovascular therapy for tandem occlusions. Methods: We conducted a retrospective study of patients who underwent endovascular therapy of tandem occlusion or occlusion of intracranial internal carotid artery/first segment of the middle cerebral artery between May 2015 and December 2019. Univariate comparisons of baseline characteristics and outcome (favorable functional outcome 90-days after treatment and mortality) were performed. We used inverse-probability-of-treatment-weights to adjust for confounders. Results: We compared 167 patients with tandem occlusion and 414 with intracranial occlusions. Patients with tandem occlusion were younger (69 years [interquartile range: 59.25-76] versus 74 [interquartile range: 64-81]; Conclusion: Patients with tandem occlusion were more frequently younger, male smokers without atrial fibrillation illustrating the different risk factors underlying these strokes. Benefit from treatment was similar between groups, supporting endovascular therapy in tandem occlusions.

Indexed as

acute ischemic strokeendovascular thrombectomytandem occlusion

Identifiers

PMID41585754
PMCPMC12778585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.